α-Synuclein neuropathology is controlled by nuclear hormone receptors and enhanced by docosahexaenoic acid in a mouse model for Parkinson's disease

Brain Pathology

Volumn 22, Issue 3, 2012, Pages 280-294

  Yakunin, Eugenia ^a   Loeb, Virginie ^a   Kisos, Haya ^a   Biala, Yoav ^a   Yehuda, Shlomo ^b   Yaari, Yoel ^a   Selkoe, Dennis J ^c   Sharon, Ronit ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Academic College of Law and Science   (Israel)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alpha synuclein; Docosahexaenoic acid; Parkinson's disease; Peroxisome proliferator activated receptors (PPAR) ; Protein oligomerization and aggregation; Retinoic X receptor (RXR)

Indexed keywords

ALPHA SYNUCLEIN; DOCOSAHEXAENOIC ACID; HORMONE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; POLYUNSATURATED FATTY ACID; RETINOID X RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN STEM; CONTROLLED STUDY; CYTOPATHOLOGY; DIET; DOPAMINERGIC NERVE CELL; FEMALE; GLIOSIS; MALE; MOUSE; MUTATIONAL ANALYSIS; NEUROPATHOLOGY; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNAPSE;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; MICE; MICE, TRANSGENIC; NEURONS; PARKINSON DISEASE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84859788725     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00530.x     Document Type: Article

References (51)

1. Argmann C, Dobrin R, Heikkinen S, Auburtin A, Pouilly L, Cock TA et al (2009) Ppargamma2 is a key driver of longevity in the mouse. PLoS Genet 5:e1000752.
2. Assayag K, Yakunin E, Loeb V, Selkoe DJ, Sharon R (2007) Polyunsaturated Fatty Acids Induce {alpha}-Synuclein-Related Pathogenic Changes in Neuronal Cells. Am J Pathol 171:2000-2011.
3. Barcelo-Coblijn G, Kitajka K, Puskas LG, Hogyes E, Zvara A, Hackler L Jr, Farkas T (2003) Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim Biophys Acta 1632:72-79. (Pubitemid 36628118)
4. Bousquet M, Saint-Pierre M, Julien C, Salem N Jr, Cicchetti F, Calon F (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J 22:1213-1225. (Pubitemid 351519975)
5. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134. (Pubitemid 39362633)
6. Broersen K, van den Brink D, Fraser G, Goedert M, Davletov B (2006) Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation. Biochemistry 45:15610-15616. (Pubitemid 46032482)
7. Calon F, Cole G (2007) Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids 77:287-293. (Pubitemid 350198857)
8. Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N et al (2005) Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci 22:617-626. (Pubitemid 41192272)
9. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294:1866-1870. (Pubitemid 33101573)
10. Choi HK, Won LA, Kontur PJ, Hammond DN, Fox AP, Wainer BH et al (1991) Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 552:67-76.
11. Chu Y, Kordower JH (2007) Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease? Neurobiol Dis 25:134-149. (Pubitemid 44765223)
12. Clayton DF, George JM (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21:249-254. (Pubitemid 28239982)
13. Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443-9449. (Pubitemid 28183026)
14. de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T (2000) Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290:2140-2144. (Pubitemid 32001593)
15. Duda JE, Lee VM, Trojanowski JQ (2000) Neuropathology of synuclein aggregates. J Neurosci Res 61:121-127.
16. Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barcelo-Coblijn GC, Nussbaum RL (2005) Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein. Mol Cell Biol 25:10190-10201. (Pubitemid 41572763)
17. George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361-372.
18. Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34:521-533. (Pubitemid 34628750)
19. Golovko MY, Rosenberger TA, Feddersen S, Faergeman NJ, Murphy EJ (2007) alpha-Synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids. J Neurochem 101:201-211. (Pubitemid 46426477)
20. Golovko MY, Barcelo-Coblijn G, Castagnet PI, Austin S, Combs CK, Murphy EJ (2009) The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response. Mol Cell Biochem 326:55-66.
21. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406.
22. Ibanez P, Bonnet AM, Debarges B, Lohmann E, Tison F, Pollak P et al (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364:1169-1171. (Pubitemid 39296605)
23. Innis SM (2008) Dietary omega 3 fatty acids and the developing brain. Brain Res 1237:35-43.
24. Jump DB, Botolin D, Wang Y, Xu J, Demeure O, Christian B (2008) Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem Phys Lipids 153:3-13.
25. Kitajka K, Sinclair AJ, Weisinger RS, Weisinger HS, Mathai M, Jayasooriya AP et al (2004) Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci USA 101:10931-10936. (Pubitemid 38989562)
26. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS et al (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318-4323. (Pubitemid 27194239)
27. Kodas E, Vancassel S, Lejeune B, Guilloteau D, Chalon S (2002) Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage. J Lipid Res 43:1209-1219. (Pubitemid 34988169)
28. Lee CH, Olson P, Evans RM (2003) Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201-2207. (Pubitemid 36629867)
29. Lee VM, Trojanowski JQ (2006) Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron 52:33-38. (Pubitemid 44479831)
30. Lengqvist J, Mata De Urquiza A, Bergman AC, Willson TM, Sjovall J, Perlmann T, Griffiths WJ (2004) Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol Cell Proteomics 3:692-703. (Pubitemid 39077000)
31. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G et al (1992) 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 355:359-361.
32. Li W, Lesuisse C, Xu Y, Troncoso JC, Price DL, Lee MK (2004) Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation. J Neurosci 24:7400-7409. (Pubitemid 39100708)
33. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O et al (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25:3032-3040. (Pubitemid 40463537)
34. Loeb V, Yakunin E, Saada A, Sharon R (2010) The transgenic over expression of {alpha}-Synuclein and not its related pathology, associates with complex I inhibition. J Biol Chem 285:7334-7343.
35. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE et al (1992) Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6:329-344.
36. Marszalek JR, Lodish HF (2005) Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu Rev Cell Dev Biol 21:633-657. (Pubitemid 41740649)
37. Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M et al (2005) Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. Neuron 46:857-868. (Pubitemid 40805347)
38. Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson's disease. Ann Rev Neurosci 28: 57-87. (Pubitemid 41098899)
39. Paxinos G, Franklin KBJ (2004) The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press: San Diego, CA.
40. Perrin RJ, Woods WS, Clayton DF, George JM (2001) Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J Biol Chem 276:41958-41962.
41. Rappley I, Myers DS, Milne SB, Ivanova PT, Lavoie MJ, Brown HA, Selkoe DJ (2009) Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype. J Neurochem 111: 15-25.
42. Samadi P, Gregoire L, Rouillard C, Bedard PJ, Di Paolo T, Levesque D (2006) Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Ann Neurol 59:282-288. (Pubitemid 43202481)
43. Shankar GM, Leissring MA, Adame A, Sun X, Spooner E, Masliah E et al (2009) Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life. Neurobiol Dis 36:293-302.
44. Sharon R, Goldberg MS, Bar-Josef I, Betensky RA, Shen J, Selkoe DJ (2001) alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci USA 98:9110-9115. (Pubitemid 32743877)
45. Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ (2003) The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 37:583-595. (Pubitemid 36262981)
46. Sharon R, Bar-Joseph I, Mirick GE, Serhan CN, Selkoe DJ (2003) Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies. J Biol Chem 278:49874-49881. (Pubitemid 37548822)
47. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302:841. (Pubitemid 37339619)
48. Suzuki K, Takahashi K, Nishimaki-Mogami T, Kagechika H, Yamamoto M, Itabe H (2009) Docosahexaenoic acid induces adipose differentiation-related protein through activation of retinoid x receptor in human choriocarcinoma BeWo cells. Biol Pharm Bull 32:1177-1182.
49. Wurtman RJ (2008) Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents. Metabolism 57(Suppl. 2):S6-10.
50. Yehuda S, Rabinovitz S, Mostofsky DI (2005) Essential fatty acids and the brain: from infancy to aging. Neurobiol Aging 26(Suppl. 1):98-102.
51. Zimmer L, Delion-Vancassel S, Durand G, Guilloteau D, Bodard S, Besnard JC, Chalon S (2000) Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41:32-40. (Pubitemid 30051839)